MIRA - MIRA Pharmaceuticals, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
2.35 0.15 (6.38%)	0.02 (0.81%)	0.04 (1.63%)	-0.25 (-9.09%)	0.15 (6.38%)	-0.01 (-0.75%)	0.9 (67.67%)	1.17 (87.97%)

Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: PreMarket

Earnings & Ratios

Basic EPS:: -0.09
Diluted EPS:: -0.09
Basic P/E:: -27.7778
Diluted P/E:: -27.7778
RSI(14) 1m:: 69.7
VWAP:: 2.49
RVol:: 9.849

Events

Period	Kind	Movement	Occurred At
1m	Price decrease 1m	2.42 -0.03 (-1.22%)	Oct 16 04:33
1m	Price increase 1m	2.45 +0.03 (+1.24%)	Oct 16 04:32
10m	Price increase 10m	2.45 +0.08 (+3.38%)	Oct 16 04:32
1m	Price increase 1m	2.43 +0.06 (+2.53%)	Oct 16 04:30
1m	Price decrease 1m	2.37 -0.08 (-3.27%)	Oct 16 04:29